- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06807489
Disordered Eating Risk in Pediatric Obesity Treatment Using a Digi-Physical Tool
Evaluation of the Risk of Developing Disordered Eating Behaviors or Eating Disorders in Children and Adolescents With Obesity Using a Digi-Physical Treatment Tool
The goal of this observational study is to evaluate the risk of developing disordered eating behavior or an eating disorder among children and adolescents with obesity who have used a digi-physical treatment tool with daily measurements conducted at home.
The primary outcomes are to:
- Evaluate the proportion of patients exhibiting documented signs of disordered eating behaviors during or after treatment (e.g., caloric restriction, skipping meals, binge eating).
- Evaluate the proportion of patients diagnosed with an eating disorder (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder) during or after treatment.
Patients at Martina Childrens Hospital, Stockholm, Sweden, who have been treated with the digi-physical treatment tool will be included and their patient records will be reviewed for eating disorder diagnosis or a disturbed eating behavior.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Children with chronic illnesses involving dietary restrictions as part of their treatment - such as obesity, diabetes mellitus, and celiac disease- are at an increased risk of developing eating disorders (ED) or disordered eating behaviors (DEB). Children with obesity are more likely to engage in unhealthy weight-control behaviors. Evidence-based, structured treatment programs for obesity do not elevate the risk of ED. On the contrary, such programs often intend to improve overall well-being. Professionally guided obesity treatment for children enhance self-esteem and has been shown to reduce both binge eating and loss of control over eating.
In this study, all participating children undergoing treatment for obesity will use a digi-physical treatment tool as a complement to behavioral treatment. This treatment tool includes daily measurements on a scale that does not show any digits, linked to a mobile app where weight development is shown as a moving average in the form of BMI standard deviation score (SDS). The app also provides an individualized target curve, visualizing the expected weight trajectory. Since weight changes in growing children are complex to interpret, BMI SDS is used as a standard metric. Objective data from the measuring device are automatically transferred to the database. Furthermore, direct communication between the clinic and the family is possible via the clinic interface and the app.
This study builds upon the investigators' previous one-year and three-year studies (ClinicalTrials.gov IDs: NCT04323215 and NCT06434259. The current follow-up study aims to evaluate the risk of developing DEB or an ED over a three-year period following the start of obesity treatment.
Approximately 400 children who have been treated with the digi-physical treatment tool will be included in the evaluation. Diagnoses and symptoms of DEB and ED will be retrieved from patient records.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Stockholm, Sweden, 114 28
- Childrens Hospital Martina
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Obesity according to International Obesity Task Force (IOTF)
- Patients aged 6 years and older who have been treated with the digi-physical treatment tool
Exclusion Criteria:
- Patients with documented disordered eating behaviors or a diagnosed eating disorder prior to the start of treatment.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Digi-physical treatment group
Behavioral treatment combined with a digi-physical treatment tool for self- monitoring of weight and facilitating communication with the clinic.
The patients are followed for three years from the start of treatment.
|
A digital treatment tool named Evira will be used to provide the treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Prevalence of Disordered Eating Behaviors
Time Frame: From start of treatment to three years follow-up
|
The proportion of patients exhibiting documented signs of disordered eating behaviors during or after treatment (e.g., caloric restriction, skipping meals, binge eating).
|
From start of treatment to three years follow-up
|
|
Referred patients
Time Frame: From start of treatment to three years follow-up
|
The proportion of patients referred to another clinic for further evaluation of a potential eating disorder.
|
From start of treatment to three years follow-up
|
|
Diagnosis of Eating Disorder
Time Frame: From start of treatment to three years follow-up
|
The proportion of patients diagnosed with an eating disorder (e.g., anorexia nervosa, bulimia nervosa, binge eating disorder).
|
From start of treatment to three years follow-up
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time of Identification of Disordered Eating or Eating Disorder Diagnosis
Time Frame: From start of treatment to three years follow-up
|
Identification of when, during the treatment process, signs of disordered eating or an eating disorder diagnosis are documented
|
From start of treatment to three years follow-up
|
|
Age of Onset of Eating Disorder
Time Frame: From start of treatment to three years follow-up
|
The age at which the first documented signs of disordered eating behaviors or a diagnosed eating disorder occured.
|
From start of treatment to three years follow-up
|
|
Association with Neurodevelopmental Disorders
Time Frame: From start of treatment to three years follow-up
|
Evaluation of the relationship between documented disordered eating behaviors or eating disorders and neurodevelopmental diagnoses, such as ADHD or autism.
|
From start of treatment to three years follow-up
|
|
Association with Mental Health Issues
Time Frame: From start of treatment to three years follow-up
|
Examination of how documented signs of disordered eating behaviors or eating disorders are related to other mental health issues, such as stress, anxiety, or depression.
|
From start of treatment to three years follow-up
|
|
Change in BMI SDS During Treatment
Time Frame: From start of treatment to the last measurement, up to three-years
|
Change in BMI SDS from the start of treatment as an indicator of treatment efficacy and its potential connection to disordered eating behaviors.
|
From start of treatment to the last measurement, up to three-years
|
|
Measurement Frequency and Adherence
Time Frame: From start of treatment to three-years follow-up
|
Analysis of how frequently patients perform the recommended daily measurements and how this correlates with the risk of disordered eating behaviors or other treatment outcomes.
|
From start of treatment to three-years follow-up
|
|
Association with Curve Patterns
Time Frame: From start of treatment to the last measurement, up to three-years
|
Analysis of the growth or weight curve patterns to identify potential factors indicating disordered eating behaviors or eating disorders.
|
From start of treatment to the last measurement, up to three-years
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Pernilla Danielsson Liljeqvist, Associate Professor, Karolinska Institutet
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Mental Disorders
- Nutrition Disorders
- Overnutrition
- Body Weight
- Signs and Symptoms, Digestive
- Overweight
- Obesity
- Pathological Conditions, Signs and Symptoms
- Nutritional and Metabolic Diseases
- Signs and Symptoms
- Pediatric Obesity
- Binge-Eating Disorder
- Feeding and Eating Disorders
- Anorexia Nervosa
- Bulimia Nervosa
Other Study ID Numbers
- Evira200
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anorexia Nervosa
-
Baylor College of MedicineEnrolling by invitationAnorexia Nervosa | Atypical Anorexia NervosaUnited States
-
Rosemary Claire RodenChildren's Miracle NetworkTerminatedBulimia Nervosa | Impulsive Behavior | Purging (Eating Disorders) | Eating Disorders | Eating Disorders in Adolescence | Anorexia Nervosa/Bulimia | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa, Binge Eating/Purging TypeUnited States
-
University of California, San DiegoActive, not recruitingAnorexia Nervosa | Bulimia Nervosa | Atypical Anorexia Nervosa | Atypical Bulimia NervosaUnited States
-
University of California, San DiegoRecruitingAnorexia Nervosa | Bulimia Nervosa | Anorexia Nervosa in RemissionUnited States
-
Fundació Institut de Recerca de l'Hospital de la...Fundació La Marató de TV3RecruitingAnorexia Nervosa | Anorexia Nervosa in Remission | Anorexia Nervosa Restricting TypeSpain
-
Duke UniversityCompletedAdolescent Anorexia Nervosa | Subthreshold Anorexia NervosaUnited States
-
Stanford UniversityNational Institute of Mental Health (NIMH); National Institutes of Health (NIH) and other collaboratorsCompletedAnorexia Nervosa | Anorexia | Eating Disorder | Eating Disorders in Adolescence | Anorexia in Adolescence | Anorexia Nervosa, Atypical | Anorexia Nervosa Restricting Type | Anorexia in ChildrenUnited States
-
Istituto Auxologico ItalianoCatholic University of the Sacred Heart; University of Turin, Italy; Open University and other collaboratorsRecruitingAnorexia Nervosa/BulimiaItaly
-
University Hospital, MontpellierCompleted
-
University of California, San FranciscoEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsEnrolling by invitationAtypical Anorexia NervosaUnited States
Clinical Trials on Digi-physical treatment tool
-
Sheikh Shakhbout Medical CityKarolinska Institutet; Evira ABCompletedChildhood Obesity | Adolescent Obesity | Treatment AdherenceUnited Arab Emirates
-
Karolinska InstitutetCompletedChildhood Obesity | Treatment AdherenceSweden
-
Region StockholmKarolinska InstitutetRecruitingDepression | Self Efficacy | Breastfeeding | Breastfeeding DurationSweden
-
Institut de Cancérologie de la LoireCentre Leon Berard; Hospices Civils de Lyon; Société BiophotonCompleted
-
Florida State UniversityCompleted
-
Karolinska InstitutetEvira ABRecruitingChildhood Obesity | Treatment AdherenceSweden
-
University Hospitals, LeicesterCompletedArthrofibrosisUnited Kingdom
-
Gaziosmanpasa Research and Education HospitalCompletedCovid19 | Post Intensive Care Unit SyndromeTurkey
-
Duke UniversityEnrolling by invitationArthritis | Hip Fractures | Tibial Fractures | Femoroacetabular Impingement | Ankle Fractures | Osteochondritis DissecansUnited States
-
Turku University HospitalTampere University Hospital; Turku University of Applied SciencesNot yet recruitingPhysical Activity During Cancer Treatment